Medical devices, healthcare technology and the business of care
PMA approval · P000053

AMS SPHINCTER 800 URINARY CONTROL SYSTEM

Boston Scientific Corp · Decision date Jun 14, 2001

MEDTECHLEDGER EXPLANATIONP000053

What did the FDA approve?

The FDA database entry records a June 14, 2001 approval for the AMS Sphincter 800 urinary prosthesis. The stated use is treatment of urinary incontinence due to reduced outlet resistance, described as intrinsic sphincter deficiency, following prostate surgery.

The device is classified under product code EZY as a mechanical/hydraulic incontinence device in the gastroenterology and urology specialty. The record does not include supplement type or reason, so no change to an earlier PMA scope is identified. The approval statement reports an intended purpose, not independent proof of safety or clinical effectiveness.

FDA approval order statement

APPROVAL FOR THE AMS SPHINCTER 800(TM) URINARY PROSTHESIS. THE DEVICE IS USED TO TREAT URINARY INCONTINENCE DUE TO REDUCED OUTLET RESISTANCE (INTRINSIC SPHINCTER DEFICIENCY) FOLLOWING PROSTATE SURGERY.
Regulatory pathway
Original PMA
Clinical specialty
Gastroenterology, Urology
Decision date
Jun 14, 2001

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P000053
Regulatory pathway
Premarket approval application
Product code
EZY
Decision code
APPR
Decision date
Jun 14, 2001
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, incontinence, mechanical/hydraulic.

Product code
EZY
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P000053 received

    Application receipt date recorded by FDA.

  2. P000053 · FDA decision

    APPR

  3. P000053/S142 · Related supplement

    AMS 800 Artificial Urinary Sphincter (AUS)

Timeline entries are records held by MedtechLedger for P000053. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000053

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA supplementSep 14, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
100 Boston Scientific Way, Marlboro, MA, 01752

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records